Voyager Therapeutics, Inc.

NasdaqGS:VYGR Stock Report

Market Cap: US$293.4m

Voyager Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:VYGR Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
03 Oct 25SellUS$36,643Nathan JorgensenIndividual7,666US$4.78
18 Aug 25SellUS$70,870Toby FergusonIndividual19,000US$3.73
02 Apr 25SellUS$37,336Alfred SandrockIndividual10,885US$3.43
02 Apr 25SellUS$34,595Toby FergusonIndividual10,086US$3.43
20 Feb 25SellUS$16,550Robin SwartzIndividual3,894US$4.25
20 Feb 25SellUS$49,616Alfred SandrockIndividual11,702US$4.24
20 Feb 25SellUS$14,079Todd CarterIndividual3,305US$4.26
11 Feb 25SellUS$24,088Todd CarterIndividual5,413US$4.45
11 Feb 25SellUS$19,393Jacquelyn SandellIndividual4,358US$4.45
11 Feb 25SellUS$74,066Alfred SandrockIndividual16,644US$4.45
11 Feb 25SellUS$30,928Robin SwartzIndividual6,950US$4.45
14 Jan 25SellUS$6,110Todd CarterIndividual1,191US$5.13
14 Jan 25SellUS$15,713Robin SwartzIndividual3,087US$5.09
23 Dec 24SellUS$36,725Robin SwartzIndividual6,500US$5.65

Insider Trading Volume

Insider Buying: VYGR insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of VYGR?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders744,1541.34%
Hedge Funds8,717,54615.7%
General Public21,382,22438.5%
Institutions24,624,88244.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 54.16% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.3%
BlackRock, Inc.
5,731,799US$30.3m5.9%no data
8.65%
Armistice Capital LLC
4,800,000US$25.4m-11.7%0.66%
7.06%
EcoR1 Capital, LLC
3,917,546US$20.7m0%0.73%
5.79%
The Vanguard Group, Inc.
3,209,919US$17.0m-0.04%no data
2.66%
Vestal Point Capital, LP
1,475,000US$7.8m18.1%0.28%
2.56%
Dimensional Fund Advisors LP
1,421,182US$7.5m-5.02%no data
2.01%
Geode Capital Management, LLC
1,116,847US$5.9m1.08%no data
2.01%
Erste Asset Management GmbH
1,116,793US$5.9m0%0.03%
1.63%
Millennium Management LLC
903,161US$4.8m817%no data
1.61%
State Street Global Advisors, Inc.
893,920US$4.7m-0.98%no data
1.29%
Farallon Capital Management, L.L.C.
715,000US$3.8m-72.2%0.02%
1.1%
T. Rowe Price Group, Inc.
610,871US$3.2m-1.87%no data
1.04%
Bank of America Corporation
576,482US$3.0m-15.3%no data
0.82%
UBS Asset Management AG
455,542US$2.4m28%no data
0.8%
Morgan Stanley
445,330US$2.4m17.7%no data
0.73%
Northern Trust Global Investments
404,482US$2.1m-1.83%no data
0.71%
Renaissance Technologies LLC
392,100US$2.1m226%no data
0.52%
RBC Dominion Securities Inc.
286,507US$1.5m0%no data
0.51%
AQR Capital Management, LLC
280,159US$1.5m-43%no data
0.47%
Fiduciary Trust Company
259,397US$1.4m0%0.01%
0.41%
The Goldman Sachs Group, Inc.
228,023US$1.2m54.2%no data
0.4%
GSA Capital Partners LLP
224,629US$1.2m0%0.07%
0.35%
JP Morgan Asset Management
194,698US$1.0m-6.16%no data
0.35%
Citadel Advisors LLC
194,653US$1.0m176%no data
0.34%
BNY Asset Management
188,656US$998.0k-0.45%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/16 23:47
End of Day Share Price 2025/10/16 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Voyager Therapeutics, Inc. is covered by 26 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Brian SkorneyBaird
Jack AllenBaird
Aydin HuseynovBenchmark Company